Senescent stromal-derived osteopontin promotes preneoplastic cell growth.
Senescent stromal-derived osteopontin promotes preneoplastic cell growth.
复制标题
DOI:
10.1158/0008-5472.can-08-2970
复制
发表时间:
2009-02-01
期刊:
影响因子:
11.2
通讯作者:
Stewart, Sheila A.
中科院分区:
文献类型:
--
作者:
Pazolli, Ermira;Luo, Xianmin;Brehm, Sarah;Carbery, Kelly;Chung, Jun Jae;Prior, Julie L.;Doherty, Jason;Demehri, Shadmehr;Salavaggione, Lorena;Piwnica-Worms, David;Stewart, Sheila A.
Alterations in the tissue microenvironment collaborate with cell autonomous genetic changes to contribute to neoplastic progression. The importance of the microenvironment in neoplastic progression is underscored by studies demonstrating that fibroblasts isolated from a tumor stimulate the growth of preneoplastic and neoplastic cells in xenograft models. Similarly, senescent fibroblasts promote preneoplastic cell growth in vitro and in vivo. Because senescent cells accumulate with age, their presence is hypothesized to facilitate preneoplastic cell growth and tumor formation in older individuals. To identify senescent stromal factors directly responsible for stimulating preneoplastic cell growth, we carried out whole genome transcriptional profiling and compared senescent fibroblasts to their younger counterparts. We identified osteopontin (OPN) as one of the most highly elevated transcripts in senescent fibroblasts. Importantly, reduction of OPN protein levels by RNAi did not impact senescence induction in fibroblasts; however, it dramatically reduced the growth-promoting activities of senescent fibroblasts in vitro and in vivo, demonstrating that OPN is necessary for paracrine stimulation of preneoplastic cell growth. In addition, we found that recombinant OPN was sufficient to stimulate preneoplastic cell growth. Finally, we demonstrate that OPN is expressed in senescent stroma within preneoplastic lesions that arise following DMBA/TPA treatment of mice, suggesting that stromal-derived OPN-mediated signaling events impact neoplastic progression.